Clinical Experience with Oxcarbazepine
- 1 June 1994
- Vol. 35 (s3) , S21-S22
- https://doi.org/10.1111/j.1528-1157.1994.tb05942.x
Abstract
Controlled studies of oxcarbazepine (OCBZ) and the largest of the open studies of OCBZ were reviewed. The overall results indicated that OCBZ has the same clinical effect as carbamazepine (CBZ) but causes fewer adverse effects. Studies of allergic toxicity seem to indicate that OCBZ may be tolerated in the majority of patients developing allergy towards CBZ. We concluded that OCBZ is a drug of first choice for the treatment of epilepsy.Keywords
This publication has 5 references indexed in Scilit:
- Cross‐Reactive Skin Eruption with Both Carbamazepine and OxcarbazepineEpilepsia, 1993
- OxcarbazepineDrugs, 1992
- A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsyEpilepsy Research, 1989
- Oxcarbazepine (GP 47.680): A Possible Alternative to Carbamazepine?Epilepsia, 1987
- Comparison of oxcarbazepine and carbamazepine: a double-blind studyEpilepsy Research, 1987